PH12016501528B1 - Internal liquid agent - Google Patents

Internal liquid agent

Info

Publication number
PH12016501528B1
PH12016501528B1 PH12016501528A PH12016501528A PH12016501528B1 PH 12016501528 B1 PH12016501528 B1 PH 12016501528B1 PH 12016501528 A PH12016501528 A PH 12016501528A PH 12016501528 A PH12016501528 A PH 12016501528A PH 12016501528 B1 PH12016501528 B1 PH 12016501528B1
Authority
PH
Philippines
Prior art keywords
liquid agent
internal liquid
ambroxol hydrochloride
tartrazine
precipitate
Prior art date
Application number
PH12016501528A
Other versions
PH12016501528A1 (en
Inventor
Masashi Yamamoto
Koji Mochizuki
Shinichi Mita
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of PH12016501528B1 publication Critical patent/PH12016501528B1/en
Publication of PH12016501528A1 publication Critical patent/PH12016501528A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An internal liquid agent containing ambroxol hydrochloride and tartrazine is a stable ambroxol hydrochloride-containing liquid agent such that change in appearance due to coloring caused by irradiation of light is suppressed and such that precipitate is not formed.
PH12016501528A 2014-02-18 2016-08-03 Internal liquid agent PH12016501528A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014028356 2014-02-18
PCT/JP2015/054203 WO2015125754A1 (en) 2014-02-18 2015-02-17 Internal liquid agent

Publications (2)

Publication Number Publication Date
PH12016501528B1 true PH12016501528B1 (en) 2017-02-06
PH12016501528A1 PH12016501528A1 (en) 2017-02-06

Family

ID=53878256

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12016501528A PH12016501528A1 (en) 2014-02-18 2016-08-03 Internal liquid agent

Country Status (3)

Country Link
JP (1) JP6372558B2 (en)
PH (1) PH12016501528A1 (en)
WO (1) WO2015125754A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3949184B2 (en) * 1995-06-13 2007-07-25 テイコクメディックス株式会社 Ambroxol hydrochloride aqueous solution
JP2000007561A (en) * 1998-06-18 2000-01-11 Nissho Corp Ambroxol hydrochloride aqueous solution preparation

Also Published As

Publication number Publication date
WO2015125754A1 (en) 2015-08-27
JP6372558B2 (en) 2018-08-15
JPWO2015125754A1 (en) 2017-03-30
PH12016501528A1 (en) 2017-02-06

Similar Documents

Publication Publication Date Title
IL292302B1 (en) Use of glutamate modulating agents with immunotherapies to treat cancer
NI201700034A (en) INDAZOLES SUBSTITUTED WITH BENZYL AS BUB1 INHIBITORS.
TWD188214S (en) Rear bumper
TWD187904S (en) Tracking device
CR20150357A (en) ANDROGEN RECEIVER MODULATOR AND USES OF THIS
CL2016000807A1 (en) Amino heteroaryl benzamides as kinase inhibitors.
TWD188215S (en) Rear bumper
AU361584S (en) Injection device without cap
SG10201804505VA (en) Near-infrared fluorescent contrast bioimaging agents and methods of use thereof
TWD170564S (en) Vessel
EA201500744A1 (en) COMBINED THERAPY WITH THE USE OF ANTIBODIES TO HER3 AND K HER2
TWD174677S (en) Wristwatch
TWD188216S (en) Front bumper
TWD171660S (en) Watchcase
BR112017008481A2 (en) antimycotic compound
TWD169239S (en) Projector equipped with camera
AU359842S (en) Housing for light
AU356410S (en) An animal suit
TWD190947S (en) Front bumper
BR112016002321A2 (en) salt shaker with distribution nozzle
TWD166471S (en) Wristwatch
AU359923S (en) Hand held light
PH12016501528A1 (en) Internal liquid agent
AU366789S (en) Housing for light
AU359043S (en) Medicament injection device with cap